BRODMANN, Marianne, Christian WISSGOTT, Andrew HOLDEN, Robert STAFFA, Thomas ZELLER, Thodur VASUDEVAN and Peter SCHNEIDER. Treatment of infrapopliteal post-PTA dissection with tack implants: 12-month results from the TOBA-BTK study. Catheterization and Cardiovascular Interventions. Hoboken: Wiley-Blackwell, 2018, vol. 92, No 1, p. 96-105. ISSN 1522-1946. Available from: https://dx.doi.org/10.1002/ccd.27568.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Treatment of infrapopliteal post-PTA dissection with tack implants: 12-month results from the TOBA-BTK study
Authors BRODMANN, Marianne (40 Austria, guarantor), Christian WISSGOTT (276 Germany), Andrew HOLDEN (554 New Zealand), Robert STAFFA (203 Czech Republic, belonging to the institution), Thomas ZELLER (276 Germany), Thodur VASUDEVAN (554 New Zealand) and Peter SCHNEIDER (840 United States of America).
Edition Catheterization and Cardiovascular Interventions, Hoboken, Wiley-Blackwell, 2018, 1522-1946.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30201 Cardiac and Cardiovascular systems
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
Impact factor Impact factor: 2.551
RIV identification code RIV/00216224:14110/18:00104168
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1002/ccd.27568
UT WoS 000440646400023
Keywords in English balloon angioplasty; critical limb ischemia; dissection; infrapopliteal arteries; peripheral artery disease; tibial artery
Tags 14110121, rivok
Tags International impact, Reviewed
Changed by Changed by: Soňa Böhmová, učo 232884. Changed: 11/2/2019 15:42.
Abstract
Objectives: The Tack implant is designed for focal, minimal metal management of dissections. This study evaluated Tacks for treating postpercutaneous transluminal angioplasty (PTA) dissection in patients with below-the-knee (BTK) arterial occlusive disease. Background: PTA is the most commonly used endovascular treatment for patients with occlusive disease of the BTK vessels. Post-PTA dissection is a significant clinical problem that results in poor outcomes, but currently there are limited treatment options for managing dissections. Methods: This prospective, single-arm study evaluated patients with CLI and BTK lesions; 11.4% were Rutherford category (RC) 4 and 88.6% were RC 5. BTK occlusive disease was treated with standard PTA and post-PTA dissections were treated with Tack placement. The primary safety endpoint was a composite of major adverse limb events (MALE) and perioperative death (POD) at 30 days. Other endpoints included: device success; procedure success (vessel patency in the absence of MALE); freedom from clinically driven target lesion revascularization (CD-TLR); primary patency; and changes in RC. Data through 12 months are presented. Results: Thirty-two of 35 (91.4%) patients had post-PTA dissection and successful deployment of Tacks. Procedural success was achieved in 34/35 (97.1%) patients with no MALEs at 30 days. The 12-month patency rate was 78.4% by vessel, 77.4% by patient, and freedom from CD-TLR was 93.5%. Significant (P < .0001) improvement from baseline was observed in RC (75% of patients improved 4 or 5 steps). Conclusion: Tack implant treatment of post-PTA dissection was safe and effective for treatment of BTK dissections and resulted in reasonable 12-month patency and low rates of CD-TLR.
PrintDisplayed: 8/10/2024 16:59